Bradley Joseph Q3 2025 Earnings Presentation Nov 5, 2025 VP Global Investor Relations Forward-Looking Statements Certain statements in this presentation are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, and are subject to the safe harbor created thereby. These statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our, or our industry's ac ...

Financial Performance - Net sales reached $1056 million, a decrease of 0.9% year-over-year[16] - Organic net sales experienced a slight decrease of 0.1% year-over-year[16] - Adjusted gross profit was $403 million, down 6.9% year-over-year[16] - Adjusted gross margin was 38.1%, a decrease of 250 basis points[16] - Adjusted operating income was $1352 million, down 2.9% year-over-year[16] - Adjusted EPS increased by 7.5% to $057[16] Segment Performance - Consumer Self-Care Americas (CSCA) net sales decreased by 1.9% year-over-year to $622 million[43] - Consumer Self-Care International (CSCI) net sales increased by 0.7% year-over-year to $4343 million[43] - Perrigo OTC brands grew by 3.6%, while Perrigo OTC store brands decreased by 3.2%[19] Strategic Initiatives - Infant formula net sales increased by 9% year-over-year[14] - Store brand and contract infant formula net sales increased by 32% year-over-year[26] - Project Energize is expected to deliver $159 million in annual run rate gross savings[30] - Supply Chain Reinvention is expected to generate total benefits between $150-$200 million by the end of 2025[30] - The sale of the Dermacosmetics business is expected to close in Q1 2026, with proceeds prioritized for accelerating net leverage goals[30, 52]

Financial Performance - Q1 2025 - Net sales were $1044 million, a decrease of 3.5% year-over-year (YoY), with organic net sales decreasing by 0.4%[30] - Adjusted gross profit increased by 8.1% YoY to $428 million, with adjusted gross margin at 41.0%, an increase of 440 basis points[30] - Adjusted operating income increased significantly by 57.6% YoY to $147 million, with adjusted operating margin at 14.0%, up by 550 basis points[30] - Adjusted EPS saw substantial growth of 106.9% YoY, reaching $0.60[30] Segment Performance - Q1 2025 - Consumer Self-Care Americas (CSCA) net sales decreased by 3.6% YoY, while organic net sales also decreased by 3.6%[63] - Consumer Self-Care International (CSCI) net sales decreased by 3.4% YoY, but organic growth was positive at 4.5%[63] - CSCA adjusted operating income increased by 90.0% YoY to $100 million[66] - CSCI adjusted operating income increased slightly by 0.2% YoY to $86 million[66] Outlook and Strategy - The company is widening its 2025 reported net sales growth target to 0%-3% and organic net sales growth to 1.5%-4.5%[72] - The company reaffirms all other 2025 financial targets, including an adjusted gross margin of approximately 40%, an adjusted operating margin of approximately 15%, and adjusted diluted EPS between $2.90 and $3.10[72] - The company expects approximately 100% operating cash flow conversion and net leverage of approximately 3.5x adjusted EBITDA at the end of 2025[70] - The company anticipates a roughly 1% gross increase in global COGS in 2025 due to tariffs, with a full-year impact of approximately 5.5%[23]